Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

Rappaport Reiches Capital Management »

Monopar Therapeutics shares owned by Rappaport Reiches Capital Management

Quarter-by-quarter ownership of Monopar Therapeutics (MNPR) shares owned by Rappaport Reiches Capital Management from 13F filings

Historical chart of Rappaport Reiches Capital Management investment in Monopar Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monopar Therapeutics held by Rappaport Reiches Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download consolidated filings csv

Download as Excel

Download consolidated filings xlsx

Quarterly reported holdings in Monopar Therapeutics by Rappaport Reiches Capital Management

Quarter filed	Position value	Share count	Share price at filing
2024-03-31	$7.3k	11k	0.68
2023-12-31	$3.6k	11k	0.34
2023-09-30	$6.6k	11k	0.62
2023-06-30	$9.1k	11k	0.86
2023-03-31	$15k	11k	1.39
2022-12-31	$25k	11k	2.37

More positions owned by Rappaport Reiches Capital Management

Vanguard Short-Term Corporate Bond Index ETF Etf (VCSH)

Vanguard Total Bond Market Index ETF Etf (BND)

DFA US Core Equity Market ETF Etf (DFAU)

Vanguard Short-Term Inflation-Protected Secs ETF Etf (VTIP)

Apple Stock (AAPL)

Vanguard Total Int'l Bond Index ETF Etf (BNDX)

DFA Int'l Core Equity Market ETF Etf (DFAI)

Schwab Charles Family Fd Amt Tax Free Mny Money Market Fund (SCTXX)

Dimensional U.s. Core Equity 2 Etf Etf (DFAC)

Nvidia Corporation Stock (NVDA)

Spdr S&p 500 Etf Etf (SPY)

CME Group Stock (CME)

Powershares QQQ Trust Etf (QQQ)

Microsoft Corp Stock (MSFT)

DFA Emerging Core Equity Market ETF Etf (DFAE)

View all positions for Rappaport Reiches Capital Management

Top funds holding Monopar Therapeutics

Millennium Management

Geode Capital Management

Virtu Financial

Rappaport Reiches Capital Management

Tower Research Capital

Goss Wealth Management

Wells Fargo & Company

Bank of America Corporation

Royal Bank of Canada

View all funds holding Monopar Therapeutics

© 2024 stockzoa - Track 13F-HR Filings for Hedge Funds and Value Investors.

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z